Suggestions
Claus Fuglsang
Chief Science Officer, Executive Vice President at Novozymes
Claus Crone Fuglsang is a prominent executive in the biotechnology industry, currently serving as the Chief Scientific Officer and Executive Vice President at Novonesis (formerly Novozymes).18 He plays a key role in the company's leadership team, contributing to its strategic direction and scientific advancements.
Professional Background
Claus Crone Fuglsang has extensive experience in the field of biotechnology and has been with Novozymes (now Novonesis) for a significant period.2 His expertise spans areas such as research and development, microbiome and genomics data analysis, and the application of biosolutions to address global challenges.5
Education
Fuglsang received his education from Herriot Watt University, which has likely contributed to his scientific background and expertise in the biotech industry.2
Recent Initiatives and Focus Areas
Sustainability and Innovation:: Fuglsang has been actively involved in promoting sustainable solutions using biotechnology. He has discussed initiatives such as transforming CO2 into nutritious food, demonstrating the company's commitment to reducing emissions and ensuring food security.7
Artificial Intelligence:: He has shown interest in the strategic importance of AI, particularly in the context of Denmark's technological strategy.4
Policy and Regulation:: Fuglsang has participated in discussions about the future of EU's regulations, indicating his involvement in shaping policy related to biosolutions and the green deal.6
Company Transition
Claus Crone Fuglsang has been a key figure in the recent merger between Novozymes and Chr. Hansen, which led to the formation of Novonesis. He has been actively communicating about this transition, emphasizing it as a new beginning for the company.3